[1]
|
Sproule, D.M. and Kaufmann, P. (2008) Mitochondrial Encephalopathy, Lactic Acidosis, and Strokelike Episodes: Basic Concepts, Clinical Phenotype, and Therapeutic Management of MELAS Syndrome. Annals of the New York Academy of Sciences, 1142, 133-158. https://doi.org/10.1196/annals.1444.011
|
[2]
|
El-Hattab, A.W., Adesina, A.M., Jones, J. and Scaglia, F. (2015) MELAS Syndrome: Clinical Manifestations, Pathogenesis, and Treatment Options. Molecular Genetics and Metabolism, 116, 4-12.
https://doi.org/10.1016/j.ymgme.2015.06.004
|
[3]
|
Bindoff, L.A. and Engelsen, B.A. (2012) Mitochondrial Dis-eases and Epilepsy. Epilepsia, 53, 92-97.
https://doi.org/10.1111/j.1528-1167.2012.03618.x
|
[4]
|
Pohl, C. and Dikic, I. (2019) Cellular Quality Control by the Ubiquitin-Proteasome System and Autophagy. Science (New York, N.Y.), 366, 818-822. https://doi.org/10.1126/science.aax3769
|
[5]
|
Bohra, S.K., Achar, R.R., Chidambaram, S.B., Pellegrino, C., Laurin, J., Masoodi, M. and Srinivasan, A. (2022) Current Perspectives on Mitochondrial Dysfunction in Migraine. The European Journal of Neuroscience, 56, 3738-3754.
https://doi.org/10.1111/ejn.15676
|
[6]
|
Sparaco, M., Feleppa, M., Lipton, R.B., Rapoport, A.M. and Bigal, M.E. (2006) Mitochondrial Dysfunction and Migraine: Evidence and Hypotheses. Cephalalgia: An International Journal of Headache, 26, 361-372.
https://doi.org/10.1111/j.1468-2982.2005.01059.x
|
[7]
|
Kang, H.C., Lee, Y.M. and Kim, H.D. (2013) Mitochon-drial Disease and Epilepsy. Brain & Development, 35, 757-761.
https://doi.org/10.1016/j.braindev.2013.01.006
|
[8]
|
Tschampa, H.J., Urbach, H., Greschus, S., Kunz, W.S. and Kornblum, C. (2013) Neuroimaging Characteristics in Mitochondrial Encephalopathies Associated with the m.3243A>G MTTL1 Mutation. Journal of Neurology, 260, 1071-1080.
https://doi.org/10.1007/s00415-012-6763-4
|
[9]
|
Kaufmann, P., Shungu, D.C., Sano, M.C., Jhung, S., Engelstad, K., Mitsis, E., Mao, X., Shanske, S., Hirano, M., DiMauro, S. and De Vivo, D.C. (2004) Cerebral Lactic Acidosis Correlates with Neurological Impairment in MELAS. Neurology, 62, 1297-1302. https://doi.org/10.1212/01.WNL.0000120557.83907.A8
|
[10]
|
Hovsepian, D.A., Galati, A., Chong, R.A., Mazumder, R., DeGiorgio, C.M., Mishra, S. and Yim, C. (2019) MELAS: Monitoring Treatment with Magnetic Reso-nance Spectroscopy. Acta Neurologica Scandinavica, 139, 82-85.
https://doi.org/10.1111/ane.13027
|
[11]
|
Malhotra, K. and Liebeskind, D.S. (2016) Imaging of MELAS. Current Pain and Headache Reports, 20, Article No. 54. https://doi.org/10.1007/s11916-016-0583-7
|
[12]
|
黄瑜, 马隆佰,田序伟, 林文彪,张汉臣. 15例线粒体脑肌病MRI影像学表现[J]. 岭南急诊医学杂志, 2019, 24(4): 337-339.
|
[13]
|
Finsterer, J. and Aliyev, R. (2020) Metabolic Stroke or Stroke-Like Lesion: Peculiarities of a Phenom-enon. Journal of the Neurological Sciences, 412, Article ID: 116726. https://doi.org/10.1016/j.jns.2020.116726
|
[14]
|
Koga, Y., Povalko, N., Inoue, E., Nakamura, H., Ishii, A., Suzuki, Y., Yoneda, M., Kanda, F., Kubota, M., Okada, H. and Fujii, K. (2018) Therapeutic Regimen of L-Arginine for MELAS: 9-Year, Prospective, Multicenter, Clinical Research. Journal of Neurology, 265, 2861-2874. https://doi.org/10.1007/s00415-018-9057-7
|
[15]
|
Liu, K., Zhou, Z., Pan, M. and Zhang, L. (2021) Stem Cell-Derived Mitochondria Transplantation: A Promising Therapy for Mitochondrial Encephalomyopathy. CNS Neu-roscience & Therapeutics, 27, 733-742.
https://doi.org/10.1111/cns.13618
|